Spago Nanomedical
Slipp dessa annonser och få en massa andra godsaker med vårt
premiumabonnemang.
BioStock: First patient dosed in Spago's phase I/IIa trial
Read the interview with Paul Hargreaves at biostock.se:
First patient dosed in Spago’s phase I/IIa trial - BioStock
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
| Datum | 2023-12-14, kl 09:46 |
| Källa | Cision |